4.8 Article

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

期刊

CELL
卷 182, 期 4, 页码 812-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2020.06.043

关键词

-

资金

  1. Medical Research Council (MRC), part of UK Research & Innovation (UKRI)
  2. National Institute of Health Research (NIHR)
  3. Genome Research Limited
  4. Wellcome Trust [110058/Z/15/Z]
  5. NIHR Sheffield Biomedical Research Centre (BRC)
  6. LANL LDRD projects [20200554ECR, 20200706ER]
  7. NIH NIAID, DHHS Interagency Agreement [AAI12007-001-00000]
  8. John and Mary Tu Foundation
  9. San Diego CFAR [AI036214]
  10. NIH NIAID [AI42742]
  11. Bill and Melinda Gates Foundation [CoVIC INV-006133]
  12. Mastercard
  13. Wellcome
  14. Emergent Ventures
  15. Overton family
  16. Wellcome Trust [110058/Z/15/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

A SARS-CoV-2 variant carrying the Spike protein amino acid change D614G has become the most prevalent form in the global pandemic. Dynamic tracking of variant frequencies revealed a recurrent pattern of G614 increase at multiple geographic levels: national, regional, and municipal. The shift occurred even in local epidemics where the original D614 form was well established prior to introduction of the G614 variant. The consistency of this pattern was highly statistically significant, suggesting that the G614 variant may have a fitness advantage. We found that the G614 variant grows to a higher titer as pseudotyped virions. In infected individuals, G614 is associated with lower RT-PCR cycle thresholds, suggestive of higher upper respiratory tract viral loads, but not with increased disease severity. These findings illuminate changes important for a mechanistic understanding of the virus and support continuing surveillance of Spike mutations to aid with development of immunological interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据